Chinese herbal medicine and bacteriophages for severe resistant pneumonia
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This early-stage trial tests a combination of a traditional Chinese herbal formula and bacteriophages (viruses that kill bacteria) to treat severe pneumonia caused by drug-resistant bacteria. The treatment is inhaled directly into the lungs and may help when standard antibiotics don't work.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with severe pneumonia caused by bacteria that resist multiple antibiotics (Klebsiella pneumoniae, Acinetobacter baumannii, or Pseudomonas aeruginosa)
- Age 18 to 85 years old
- Willing to undergo lung sampling procedures, including a bronchoscopy (camera test of airways) and receive inhaled bacteriophage treatment
- Not pregnant, not breastfeeding, and not immunocompromised (no weakened immune system or immunosuppressive medications)
- No active tuberculosis, lung abscess, or severe COPD, and have not been on a mechanical ventilator for more than 60 days
- No known allergies to bacteriophage products or the herbal formula ingredients
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a Chinese herbal formula (Yiqi Huoxue Jiedu) and inhaled bacteriophages (viruses that kill bacteria) to standard care can help treat severe pneumonia caused by drug-resistant bacteria like Klebsiella, Acinetobacter, or Pseudomonas. It is for adults aged 18 to 85 who are not pregnant or immunocompromised and can undergo a bronchoscopy to collect samples.
This trial studies whether Chinese herbal medicine can help people hospitalized with pneumonia. It compares the herbal treatment to usual care to see if it improves recovery.
This trial tests a combination of traditional Chinese and Western medicine for adults with severe pneumonia caused by bacteria that are resistant to multiple antibiotics. It aims to see if this combined approach can improve treatment outcomes.
This trial is testing whether a special traditional Chinese medicine formula can help treat pneumonia caused by bacteria that don't respond to many standard antibiotics. If you are hospitalized with this type of pneumonia, the study aims to find a new treatment option to help you fight the infection.
This trial tests whether a cocktail of bacteriophages (viruses that kill bacteria) can treat ventilator-associated pneumonia caused by hard-to-treat bacteria like Klebsiella, Acinetobacter, or Pseudomonas. It may help patients who have not responded to standard antibiotics.
This study tests whether adding NRICM102, a traditional Chinese medicine, to standard antibiotic treatment helps hospitalized patients with community-acquired pneumonia (a lung infection acquired outside a hospital) recover better. You would receive the herbal medicine by mouth along with your regular antibiotics.
Hear when a new Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.